Skip to content
Cold-chain shipping · Ships from Canada · Research use only
Recovery

VIP Peptide in Canada

VIP is vasoactive intestinal peptide, a messenger peptide 28 amino acids (protein building blocks) long. It was found in pig intestine in 1970, then all over the body. Its clinical research has mostly been in lung disease. A big trial in COVID-19 lung failure was stopped early in 2022 because it was unlikely to show a benefit.

VIP peptide 5mg vial, Pro Peptide
$64.77CAD per vial

Pack prices and discount codes don't combine. You always get the bigger saving.

Strength5mg
1

Sold for laboratory research use only. Not for human or veterinary use. 19+.

Amino acids
28
Isolated from pig intestine
1970
Half-life in plasma, roughly
2min
Phase 3 stopped for futility
2022
Approved product, a urology combination
1

What is VIP?

The plain-language version, first.

VIP is a messenger peptide named for the gut, the first place anyone found it.

Naming a molecule after where you found it is risky, because molecules move.

Vasoactive Intestinal Peptide was isolated from pig intestine in 1970. Then it turned up in the lungs.

The brain, the pancreas, immune cells. The list kept going.

It is less an intestinal peptide than a general-purpose signal the intestine happened to be caught holding.

Twenty-eight residues, working through two receptors spread across half the body's tissues.

That spread is the whole character of this molecule: genuinely important, and genuinely everywhere.

Which sounds like an asset right up until you try to aim it.

What is VIP peptide?

What researchers watch it do.

Here's the problem with signals the body uses everywhere.

A molecule that relaxes airway muscle also does things to blood vessels, gut, immune cells and neurons, because those tissues all read the same channel.

Using VIP is less like pressing a button and more like making an announcement over the building's PA system.

Every tissue with the receptor hears it. The interesting research question was always whether you could get the announcement to only the department you meant.

Add the standard peptide problem, a half-life measured in minutes, and the delivery challenge stacks on top of the targeting one.

Here's the honest part. Physiological importance and pharmaceutical usefulness are cousins, not twins.

This molecule is unambiguously the first. The 461-patient trial in the next section is what happened when somebody tested the second.

What does the research say about VIP?

What the studies found, and where they stand.

One number carries this file: 461.

That is the patient count of the phase 3 trial of a VIP-based drug candidate that was stopped for futility, which is trial language for the data showing the answer would be no, so continuing was pointless.

Futility is not scandal. It is the system working: a real hypothesis, tested properly, answered clearly.

A futility stop is arguably more informative than most positive small studies, because it had the statistical power to mean something.

Basic VIP biology remains foundational and widely cited. The drug-development thread ended where the data ended it.

A genuinely important molecule whose big test came back negative. Both halves belong on the page, and most pages selling it only carry the first.

Have a look at current stock and vial sizes.

What did the lab find in our VIP?

The lab's numbers for the lot on the shelf.

98.76%HPLC purity
Lot 2216-316
LaboratoryJanoshik Analytical
TestedMay 2026
MethodHPLC + mass spectrometry
Size5 mg, freeze-dried powder
Reported resultsas reported by the laboratory
HPLC purity
98.76%
Identity
Confirmed
Measured content
label 5 mg5.28 mg

See the lab results page

What's in a vial of VIP?

The chemistry, exactly as released.

Handling
FormatFreeze-dried powder
Storage−20 °C, desiccated
ReconstitutionBacteriostatic water
Work out the drawPeptide calculatorLab resultsLot 2216-316

Who studies VIP?

Who tends to order this one, and why.

  1. 1

    Pulmonary medicine

    Acute lung injury and ARDS were the lead indications for two decades. The definitive trial in COVID-19 respiratory failure was negative.

  2. 2

    Urology

    The only branch that produced an approved product, because direct local injection sidesteps the two-minute half-life entirely.

  3. 3

    Neuroendocrinology

    VIP is a widespread neurotransmitter with roles in circadian rhythm and autonomic signalling, well beyond the gut it was named after.

  4. 4

    Sarcoidosis researchers

    The FDA orphan designation in August 2021 rested on open label exploratory clinical experience rather than a controlled trial.

Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.

Where did VIP come from?

How it got here.

Said and Mutt were purifying peptides from pig intestine in 1970 and picked this one out by its ability to dilate blood vessels. That is where the name comes from: vasoactive, intestinal, peptide. It turned out to be far more widely distributed than the gut, appearing throughout the nervous system and the lung.

The therapeutic story splits in two. One branch went into rare lung disease, sponsored largely by mondoBIOTECH in Liechtenstein, and produced three EMA orphan designations between 2003 and 2007 and no medicines. The other branch went into urology, where local injection sidesteps the half-life problem entirely, and produced the only approved product.

The COVID programme, run under the name ZYESAMI, was the largest and best-funded attempt at the first branch. It ended in 2022 with a futile phase 3 and two declined authorisations.

  1. 1

    Pig intestine, 1970

    Said and Mutt isolated it by its vasodilator activity and published in Science. It turned out to be distributed far beyond the gut, through the nervous system and lung.

  2. 2

    Orphan designations, 2003 to 2007

    Three from EMA for pulmonary hypertension, acute lung injury and sarcoidosis, all sponsored by mondoBIOTECH. None produced a medicine.

  3. 3

    The COVID programme ends

    Inhaled trial terminated, two FDA emergency authorisations declined, and a 461-patient phase 3 stopped for futility in May 2022.

How do I buy VIP in Canada?

What ships, how fast, and the paperwork.

Same day out of British Columbia. Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.

Then into the fridge. Keep it cold and keep it dark. Sealed and freeze-dried it handles a rough trip without ice. Once it lands, fridge.

The half-life is the whole story. Two minutes in plasma. Every trial that produced a real result used continuous infusion or direct local injection. That is a fact about the molecule, not a formulation problem waiting to be solved by a vial.

What else do people ask?

5 answers, none of them dodges.

Did VIP work in its COVID-19 trial?

No. TESICO, published in Lancet Respiratory Medicine in 2023, randomised 471 patients with 461 in the analysis. Recovery at day 90 gave an odds ratio of 1.11, confidence interval 0.80 to 1.55, p equals 0.54. Day-90 mortality was 38 percent on aviptadil against 36 percent on placebo. The data safety monitoring board stopped the trial for futility in May 2022.

Is any VIP product approved anywhere?

Yes, one, and it is in urology rather than any of the indications VIP is usually discussed for. The Scottish Medicines Consortium accepted it for restricted second-line use in December 2017. No VIP product is approved for any lung, inflammatory or metabolic indication anywhere in the world.

What is VIP half-life?

About two minutes in plasma. This is the single most consequential fact about the compound. It is why every clinical programme has used continuous intravenous infusion, nebulisation, or direct injection into the target tissue rather than intermittent systemic dosing.

Did FDA ever authorise VIP for COVID-19?

No. FDA declined an emergency use authorisation on 4 November 2021, stating it was unable to issue the authorisation due to insufficient data regarding the known and potential benefits and risks, having reviewed safety data in only 131 randomised patients. A second, narrower request focused on critically ill patients was declined in June 2022.

What do the orphan designations mean?

Less than they sound like. EMA granted three: pulmonary arterial hypertension in December 2003, acute lung injury in August 2006, and sarcoidosis in September 2007. An orphan designation is a development incentive granted early, not evidence of efficacy. All three are roughly twenty years old and none has ever led to a marketing authorisation in those indications.

What pairs well with VIP?

What researchers stack alongside it.

Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as VIP Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

RecoveryThymosin Alpha-1 Peptide

A 28-building-block peptide first found in the thymus, the gland where your immune system's T cells go to school. Scientists study it as a teacher at that school, and as Zadaxin it's an approved drug in more than 30 countries, though not Canada or the US.

1
In stock · ships same-day with ice pack
LongevityThymalin Peptide

A mix of small proteins from the thymus of calves, the gland where immune cells learn their job, so it's a grab bag, not one molecule. Russia still studies and uses it for immunity and ageing, but no Western regulator has looked at it.

1
In stock · ships same-day with ice pack

Supplies for the lab

SuppliesBacteriostatic Water

The water every freeze-dried vial needs, and the one item everybody forgets. Sterile water with a preservative, so one vial lasts more than one draw.

1
In stock · ships same-day with ice pack

What else is in Recovery?

Other compounds in the same research category.

See all 12 in Recovery →

Ready to order VIP?

One last look before you decide.

Freeze-dried, lab results on the page, ships cold

You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, VIP is right here.

For research use only

Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.

Page last updated October 25, 2026. Reviewed by the Pro Peptide team.

What do people search for with VIP?

Related searches.